CHINA GEWANG BIOTECHNOLOGY, INC. Increase (Decrease) in Accrued Liabilities
CHINA GEWANG BIOTECHNOLOGY, INC. reported Increase (Decrease) in Accrued Liabilities of $218.98 thousand for the 6-month period ending 2017-05-31, per its 10-Q filed 2017-07-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2017-07-17
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities for the quarter ending 2017-05-31 was $147.76K, a 1652.16% increase year-over-year.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities for the quarter ending 2017-02-28 was $71.22K.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities for the quarter ending 2016-05-31 was $8.43K.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities for the quarter ending 2016-02-29 was -$90.63K.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities for fiscal 2016 was $207.69K, a 37.24% decline from fiscal 2015.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities for fiscal 2015 was $330.94K, a 3416.85% increase from fiscal 2014.
- CHINA GEWANG BIOTECHNOLOGY, INC. increase (decrease) in accrued liabilities for fiscal 2014 was $9.41K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2017-05-31 | $147.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-17 | $218.98K 10-Q · filed 2017-07-17 | ||
| 2017-02-28 | $71.22K 10-Q · filed 2017-04-12 | |||
| 2016-11-30 | $207.69K 10-K · filed 2017-02-10 | |||
| 2016-05-31 | $8.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-17 | -$82.20K 10-Q · filed 2017-07-17 | $64.84K 10-Q · filed 2016-10-14 | |
| 2016-02-29 | -$90.63K 10-Q · filed 2017-04-12 | |||
| 2015-11-30 | $330.94K 10-K · filed 2017-02-10 | |||
| 2015-05-31 | $115.67K 10-Q · filed 2016-10-14 | |||
| 2014-11-30 | $9.41K 10-K · filed 2017-02-10 |